SynthesisJournal of neurology2022

Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression.

Dimitrios Papadopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.